Interviews /
by Rachael Jones -
4 years ago
16 Dec 2019 - Botanix Pharmaceuticals Limited (ASX:BOT) Founder Matthew Callahan talks about the company's Phase 2 US trial results for severe acne, plans for its Phase 3 trails, i…
Interviews /
by Jessica Amir -
5 years ago
02 Aug 2019 - Botanix Pharmaceuticals Limited (ASX:BOT) Executive Director Matthew Callahan talks about the company's cap raising, promising proof points in the performance of cann…
Market Reports /
by Jessica Amir -
5 years ago
27 Jun 2019 - Material sector continues to shine with Fortescue Metals (ASX:FMG) rising 5.5%, gold holds six-year highs. Botanix Pharmaceuticals (ASX:BOT) shares rally 76% higher Y…
Interviews /
by Jessica Amir -
5 years ago
27 Jun 2019 - Botanix Pharmaceuticals Limited (ASX:BOT) President, Vince Ippolito, talks about interim results from the company's BTX 1308 psoriasis phase 1b study and opportunitie…
Market Reports /
by Jessica Amir -
5 years ago
20 Jun 2019 - Aus shares hit new fresh high & the ASX200 is now 165pts off the all-time high. Caltex (ASX:CTX) loses 18%, 5-yrs of gains on profit/earnings downgrade. Resolute Mini…
Market Reports /
by Jessica Amir -
5 years ago
19 Jun 2019 - Most sectors rise up on ASX with ASX200 hitting a new fresh high of 6,644pts. Nanosonics (ASX:NAN) shares hit all-time high on France support. Orthocell (ASX:OCC) pro…
Market Reports /
by Jessica Amir -
6 years ago
26 Jun 2018 - Market at Midday. APN Outdoor (ASX:APO) trades 0.5% higher on being taken over for $1.1b and declaring special div. Syrah Resources (ASX:SYR) trades higher, outperfor…
Company News /
by Anna Napoli -
6 years ago
13 Jun 2018 - Medical dermatology company, Botanix (ASX:BOT) has today announced that it has received Australian approval for a phase 2 acne study